Intuitive Surgical, Inc. $ISRG Shares Sold by Rise Advisors LLC

Rise Advisors LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 354 shares of the medical equipment provider’s stock after selling 24 shares during the quarter. Rise Advisors LLC’s holdings in Intuitive Surgical were worth $192,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of ISRG. Brighton Jones LLC increased its position in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the period. Bank Pictet & Cie Europe AG increased its holdings in Intuitive Surgical by 0.5% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider’s stock valued at $99,678,000 after buying an additional 883 shares during the last quarter. Toronto Dominion Bank increased its holdings in Intuitive Surgical by 11.6% in the fourth quarter. Toronto Dominion Bank now owns 202,571 shares of the medical equipment provider’s stock valued at $105,734,000 after buying an additional 21,079 shares during the last quarter. Strategic Wealth Partners Ltd. purchased a new position in Intuitive Surgical in the fourth quarter valued at $301,000. Finally, Stonebrook Private Inc. increased its holdings in Intuitive Surgical by 7.7% in the fourth quarter. Stonebrook Private Inc. now owns 492 shares of the medical equipment provider’s stock valued at $257,000 after buying an additional 35 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 1.4%

NASDAQ ISRG opened at $449.68 on Monday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The business’s 50-day moving average price is $485.67 and its 200 day moving average price is $507.82. The firm has a market cap of $161.20 billion, a P/E ratio of 62.72, a P/E/G ratio of 4.71 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same quarter last year, the company posted $1.78 earnings per share. The business’s revenue was up 21.4% on a year-over-year basis. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock valued at $21,716,492 over the last quarter. 0.70% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Royal Bank Of Canada reissued an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a report on Tuesday, August 19th. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, July 26th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a report on Wednesday, July 23rd. Finally, Truist Financial raised their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.